Updated Blog Image

5 Trends in Diabetes Care from the ADA 77Th Scientific Sessions

Posted on
This weekend, physicians, researchers, diabetes corporations and non-profits from everywhere in the world come together for the American Diabetes Association 77th Scientific Sessions. It’s the most important gathering of the diabetes scientific group all yr. But what does it mean for you, someone dwelling with and doing all of your greatest to handle your diabetes every day?

As the Chief Patient Officer for Medtronic Diabetes, that’s what I’m asking myself.  And I’m impressed by the extraordinary innovation pushed by so many passionate individuals to improve the lives of individuals dwelling with sort 1, sort 2 or pre-diabetes. Individuals such as you. The research and greatest practices these specialists share at ADA are what drives the type of care you obtain out of your healthcare staff as well as the medicine and know-how out there to you. So, it’s pretty necessary to you.

This yr, I’d like to do my greatest to share with you what I’m seeing and studying this weekend. And hear your questions and feedback. Starting with this weblog, where I’ll speak concerning the prime four themes I anticipate to see and listen to in the subsequent few days. I’ll be sharing day by day updates on Instagram, and internet hosting a Facebook Live event from the convention in San Diego on Sunday at 4pm. I hope you comply with along and be a part of us in a fantastic dialog.

1. Automated Insulin Delivery

Automated insulin supply, closed loop techniques, a man-made pancreas. No matter you call it, apart from a biological remedy, these automated techniques have been the “holy grail” in the diabetes group for a very long time. This yr’s agenda is full of posters and shows displaying work from many teams towards this aim. At Medtronic, we’re thrilled to have the ability to supply the one commercially obtainable system that features automation. The MiniMed 670G system is the world’s first hybrid closed loop system – with our SmartGuard HCL know-how it will probably automate basal insulin delivery, however still requires you to bolus for meals and calibrate the sensor. We’ll be displaying knowledge not just on the clinical outcomes that folks on the system experienced, but in addition on how their quality of life We expect this can be a really essential metric to track and I feel we’ll start to see extra of this throughout the business, which is a very good thing.

2. Caring for the Entire Patient/Individual

I’m really excited to see increasingly more emphasis on a more holistic view of caring for individuals with diabetes. You’ve gotten taught me that – whether or not you reside with sort 1 or sort 2 diabetes – managing diabetes is about so much greater than the numbers. The emotional toll might be big. And each patient isn’t just a patient, but in addition an individual – who’s sadly required to cope with all life’s ups and downs, stresses and fears while carrying the physical and psychological load of diabetes.

This yr, I’m glad to see periods on the influence of the psycho-social features of diabetes as well as results from those making an attempt new, “entire individual” approaches. Our staff can be sharing a poster from our Netherlands-based Diabeter clinic. Clinically and professionally unbiased, Diabeter supplies complete and individualized care for youngsters and younger adults dwelling with sort 1 diabetes. We’ve seen great results from the warm, motivating non-clinical expertise, 24/7 help and digital instruments. And we’re working on the way to increase the mannequin to assist extra individuals all over the world.

3. Digital/Related Well being

Immediately, who isn’t making an attempt to use digital instruments to make whatever they do more handy, efficient or impactful? The diabetes group is not any exception. I feel our problem is the way to be sure that cellular apps and different digital instruments present invaluable info that empowers – not only a high quantity of knowledge that is overwhelming or confusing. I feel we’re heading in the right direction with tools such as the Sugar.IQ app, developed by Medtronic and IBM Watson. We’re excited to use cognitive computing to research CGM knowledge in addition to details about meals, train and so forth. to recognize patterns and tendencies after which present meaningful insights to the individual with diabetes so they can be extra proactive than reactive about their diabetes.

Other articles you might like;

Leave a Reply

Your email address will not be published. Required fields are marked *